• Discovery through Diversity
    About GHUCCTS

    The Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) was founded to advance the health of our community and our nation by performing research that will have a positive impact on human health and well-being.

    Learn More, Test
  • Discovery through Diversity
    Institutions

    Member institutions provide varied backgrounds, diverse research activities, and greater exposure to a holistic community. These unique areas of interest allow for the exchange of ideas and discovery, creating a dynamic research community that supports the larger District of Columbia community.

    Learn More, Test
  • Discovery through Diversity
    Laboratory Science

    Many GHUCCTS investigators work in translational science and basic laboratories where discoveries occur. These discoveries form the basis for new therapies, drugs, and methods of disease prevention.

    Learn More, Test
  • Discovery through Diversity
    Clinical Research

    Discovery leads to clinical research studies in human volunteers with or without specific diseases. Careful testing in humans is a crucial step to adopting new basic discoveries into clinical practice.  This step is referred to as the "T1" phase of translation.

    Learn More, Test
  • Discovery through Diversity
    Community Research

    Discovery also occurs in the community, where health problems are assessed and the impact of various treatments is measured across groups of patients. This step is referred to as "T2" phase of translation.

    Learn More, Test
 

Upcoming Events

Georgetown Howard Universities Center for Clinical and Translational Science
May
24

Clinical Research Network Seminar

Building D

More Details
Jun
2

Symposium on Heart Disease in Women

More Details
Jun
5

MCMi Regulatory Science Symposium

More Details

Meet Our Researchers

Robert E. Ratner, MD, FACP, FACE  is Professor of Medicine at Georgetown University Medical School & Senior Research Scientist at the MedStar Health Research Institute in metropolitan Washington, DC.  


Dr. Robert E. Ratner is recently completed a sabbatical as a Robert Wood Johnson Foundation Health Policy Fellow, having served as the study director for the IOM Comparative Effectiveness Research Priorities Committee....read more